+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
Desmoid Tumors - Epidemiology Forecast - 2032 - Product Thumbnail Image

Desmoid Tumors - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Actinic Keratosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Actinic Keratosis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Malignant Pleural Mesothelioma - Epidemiology Forecast - 2032 - Product Thumbnail Image

Malignant Pleural Mesothelioma - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Zollinger Ellison Syndrome - Epidemiology Forecast - 2032 - Product Thumbnail Image

Zollinger Ellison Syndrome - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
HER2 Lung Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

HER2 Lung Cancer - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Leptomeningeal Metastases - Epidemiology Forecast - 2032 - Product Thumbnail Image

Leptomeningeal Metastases - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Leiomyosarcoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Leiomyosarcoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Metastatic Melanoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Metastatic Melanoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Pegfilgrastim- Biosimilar Insight, 2022 - Product Thumbnail Image

Pegfilgrastim- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Blinatumomab - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

Blinatumomab - Emerging Insight and Market Forecast - 2030

  • Report
  • February 2021
  • 50 Pages
  • Global
From
From
Nexavar (Sorafenib) - Drug Insight and Market Forecast - 2030 - Product Thumbnail Image

Nexavar (Sorafenib) - Drug Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
From
Digital Marketing Trends in Hepatocellular Carcinoma - Product Thumbnail Image

Digital Marketing Trends in Hepatocellular Carcinoma

  • Report
  • September 2022
  • 30 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more